News & Updates

Angiolutions treats first patient in clinical investigation of its A³‑Shield® system for early-stage abdominal aortic aneurysms

Second US patent granted in May, first EU patent granted in July; Increasing total patent portfolio to 16 patents and applications; Intellectual property (IP) portfolio protects innovation from multiple angles.

Angiolutions strengthens intellectual property protection for its early aortic aneurysm treatment: second US patent granted

Second US patent granted in May, first EU patent granted in July; Increasing total patent portfolio to 16 patents and applications; Intellectual property (IP) portfolio protects innovation from multiple angles.

Angiolutions announces advisory board to accelerate early-stage treatment for abdominal aortic aneurysms

July 3, 2024 – Angiolutions announces its Advisory Board, comprising industry leaders, distinguished researchers, and clinicians from world-renowned institutions. Each member brings unique expertise to advance Angiolutions' mission of delivering the first implant designed to prevent abdominal aortic aneurysms at an early stage to patients.

Angiolutions wins START HEALTHCARE competition

June 18, 2024 – Angiolutions won first place in the competition START HEALTHCARE which was held at the MedtecLIVE Tradefair in Stuttgart.

Stay in touch

receive update emails a few times a year

stay in touch

Angiolution explained briefly

An easy-to-understand explainer video about the causes and treatment of vascular diseases.

You are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information

Media Kit

further content about Angiolutions

Document title

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Document title

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Contact

Please leave your message here

contact